Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dermatophagoides farinae allergen extract + phleum pratense extract
- Development stage
- Unknown
- Lead developer
- Stanford University
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Sublingual
01
Overview
This is an investigational combination sublingual immunotherapy (SLIT) developed by Stanford University for the treatment of allergies. It is composed of allergen extracts from house dust mite (*Dermatophagoides farinae*) and Timothy grass (*Phleum pratense*). By administering the allergens under the tongue, the therapy is designed to induce immune tolerance and reduce the symptoms associated with allergic rhinitis, allergic conjunctivitis, and asthma. [2] A Phase 1 clinical trial has been conducted to evaluate the safety and tolerability of this combination therapy in both children and adults. [2]
- Other names
- sublingual immunotherapy-Stanford University-allergic rhinitis-allergic conjunctivitis-asthma
Beyond the preview
Go deeper on dermatophagoides farinae allergen extract + phleum pratense extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dermatophagoides farinae allergen extract + phleum pratense extract.